B.A. Swarthmore College 2005
M.A. The University of Texas at Austin 2011
APA-Accredited Pre-Doctoral Clinical Psychology Internship Indiana University School of Medicine 2013–2014
Ph.D. (Clinical Psychology) The University of Texas at Austin 2014

Selected Grants/Awards

• 2023-2026: Principal Investigator, Assessing real-world evidence of the effects of opioid analgesic tapering on substance-related problems (NIH/NIDA Grant #R01DA059026) 
• 2021: Trustees Teaching Award, Indiana University School of Public Health-Bloomington 
• 2021-2024: Principal Investigator, A population-based, genetically informed study of the effects of chronic pain on suicidal behavior (American Foundation for Suicide Prevention Grant #SRG-0-133-19) 
• 2019-2024: Co-Investigator, Maternal use of prescribed opioid analgesics and risk of adverse offspring outcomes (NIH/NIDA Grant #R01DA048042) 
• 2016-2022: Principal Investigator, Pharmacoepidemiologic studies of prescription opioid analgesic risks (NIH/NIDA Grant #K99/R00DA040727) 
• 2019: Rising Star, Association for Psychological Science

Scholarly Interests

Dr. Quinn studies the biopsychosocial causes and health consequences of substance use. His team conducts research on a range of substances, from alcohol and cigarettes to opioids and prescribed stimulants. This work also ranges across the lifespan, assessing prenatal drug exposure, adolescent substance use, and medication treatments in adults. Much of Dr. Quinn's current research examines pain and its treatment with opioid medications, using longitudinal health data on individuals and families and methods from epidemiology and behavioral genetics. As a licensed psychologist, Dr. Quinn is also interested in suicide prevention and other topics in mental health.

• Summit, A. G., Chen, C., Pettersson, E., Boersma, K., D’Onofrio, B. M., Lichtenstein, P., & Quinn, P. D. (2024). Preliminary validation of a general factor model of chronic overlapping pain conditions. Journal of Pain, 25, 104502.
• Chen, C., Pettersson, E., Summit, A. G., Boersma, K., Chang, Z., Kuja-Halkola, R., Lichtenstein, P., & Quinn, P. D. (2023). Chronic pain conditions and risk of suicidal behavior: A 10-year longitudinal co-twin control study. BMC Medicine, 21, 9.
• Quinn, P. D., Chang, Z., Pujol, T. A., Bair, M. J., Gibbons, R. D., Kroenke, K., & D’Onofrio, B. M. (2023). Association between prescribed opioid dose and risk of motor vehicle crashes. Pain, 164, e228-e236.
• Quinn, P. D., Chang, Z., Bair, M. J., Rickert, M. E., Gibbons, R. D., Kroenke, K., & D’Onofrio, B. M. (2022). Associations of opioid prescription dose and discontinuation with risk of substance-related morbidity in long-term opioid therapy. Pain, 163, e588-e595.
• Quinn, P. D., Fine, K. L., Rickert, M. E., Sujan, A. C., Boersma, K., Chang, Z., Franck, J., Lichtenstein, P., Larsson, H., & D'Onofrio, B. M. (2020). Association of opioid prescription initiation during adolescence and young adulthood with subsequent substance-related morbidity. JAMA Pediatrics, 174, 1048-1055.
• Sujan, A. C., Quinn, P. D., Rickert, M. E., Wiggs, K. K., Lichtenstein, P., Larsson, H., Almqvist, C., Öberg, A. S., & D'Onofrio, B. M. (2019). Maternal prescribed opioid analgesic use during pregnancy and risk for adverse birth outcomes: A population-based study. PLOS Medicine, 16, e1002980.
• Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017). ADHD medication and substance-related problems. American Journal of Psychiatry, 174, 877-885.
• Quinn, P. D., Rickert, M. E., Weibull, C. E., Johansson, A. L. V., Lichtenstein, P., Almqvist, C., Larsson, H., Iliadou, A. N., & D’Onofrio, B. M. (2017). Association between maternal smoking during pregnancy and severe mental illness in offspring. JAMA Psychiatry, 74, 589-596.